<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>diabetesmanagement on Gloucestershire Daily</title><link>https://gloucestershiredaily.co.uk/tags/diabetesmanagement/</link><description>Recent content in diabetesmanagement on Gloucestershire Daily</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><lastBuildDate>Mon, 15 Jun 2026 12:08:52 +0000</lastBuildDate><atom:link href="https://gloucestershiredaily.co.uk/tags/diabetesmanagement/index.xml" rel="self" type="application/rss+xml"/><item><title>New Pill Offers Promising Weight Loss and Diabetes Management Without Common Side Effects</title><link>https://gloucestershiredaily.co.uk/new-pill-offers-promising-weight-loss-and-diabetes-management-without-common-side-effects/</link><pubDate>Mon, 15 Jun 2026 12:08:52 +0000</pubDate><guid>https://gloucestershiredaily.co.uk/new-pill-offers-promising-weight-loss-and-diabetes-management-without-common-side-effects/</guid><description>A groundbreaking new pill could revolutionize the treatment of diabetes and obesity by targeting metabolism directly—with fewer side effects than current therapies. Recent trial results show this innovative medication reduces blood sugar levels and enhances fat burning without causing appetite suppression or muscle wasting, two significant drawbacks of many existing weight loss drugs.
The study, published in the journal Cell, involves researchers from Karolinska Institutet and Stockholm University. Unlike widely prescribed GLP-1 medications such as Wegovy, which require injections and work by altering appetite signals between the gut and brain, this new drug—classified as GRK-biased adrenergic agonists—acts through a completely different mechanism.</description></item></channel></rss>